San Carlos, CA, United States of America

Ihab S Darwish

USPTO Granted Patents = 55 (Patent Applications = 9)

CIPO Patents = 5 (Patent Applications = 6)

EPO Patents = 14 (Patent Applications = 15)

Average Co-Inventor Count = 5.9

ph-index = 7

Forward Citations = 135(Granted Patents)

Location History:

San Mateo, CA (US) (2009 - 2010)
South San Franciso, CA (US) (2022)
South San Francisco, CA (US) (2022 - 2023)
San Carlos, CA (US) (2011 - 2024)

Company Filing History:

50 out of 488

Rigel Pharmaceuticals, Incorporated

Bristol-myers Squibb Compnay

patents

4. 1 out of 1

Rigl Pharmaceutical, Inc.

patent

5. 1 out of 4,442

Eli Lilly and Company

patents

6. 1 out of 41

Bristol Meyers Squibb Company

patents

7. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

55 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12459941 - Tricyclic IRAK inhibitors (2025-11-04),

2. 12441723 - Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations (2025-10-14),

3. 12357623 - Method for treating a disease or condition using a pyrazole compound or formulation thereof (2025-07-15),

4. 12297202 - RIP1K inhibitors (2025-05-13),

5. 12227508 - TGF-β inhibitors (2025-02-18),

6. 12043629 - RIP1K inhibitors (2024-07-23),

7. 12006314 - Anti-cancer nuclear hormone receptor-targeting compounds (2024-06-11),

8. 11919890 - RIP1 inhibitory compounds and methods for making and using the same (2024-03-05),

9. 11834458 - Anti-cancer nuclear hormone receptor-targeting compounds (2023-12-05),

10. 11672791 - Tyrosine kinase inhibitors (2023-06-13),

11. 11667643 - RIP1K inhibitors (2023-06-06),

12. 11584758 - RIP1K inhibitors (2023-02-21),

13. 11578078 - Heterocyclic RIP1 inhibitory compounds (2023-02-14),

14. 11564930 - RIP1 inhibitory compounds and methods for making and using the same (2023-01-31),

15. 11466018 - TGF-β inhibitors (2022-10-11),

Title: Ihab S Darwish: A Trailblazer in Innovation

Introduction:

Ihab S Darwish, a pioneering inventor based in San Carlos, CA (US), is reshaping the future of technology through his relentless pursuit of innovation. With an impressive 47 patents to his name, Darwish is a true luminary in the field of technology.

Latest Patents:

Darwish's latest patents include groundbreaking advancements in the medical field. One patent delves into anti-cancer nuclear hormone receptor-targeting compounds, showcasing his commitment to revolutionizing cancer treatment. Another patent focuses on tyrosine kinase inhibitors, highlighting his dedication to developing novel pharmaceutical compounds.

Career Highlights:

Throughout his career, Darwish has made invaluable contributions to prominent companies such as Rigel Pharmaceuticals, Incorporated, and Bristol-Myers Squibb Company. His innovative spirit and technical expertise have paved the way for transformative advancements in the pharmaceutical industry.

Collaborations:

Darwish has collaborated with esteemed colleagues, including Jiaxin Yu and Rajinder Paul Singh, to bring his visionary ideas to life. Their collective efforts have resulted in the development of impactful technologies that are shaping the future of medicine.

Conclusion:

Ihab S Darwish's unwavering commitment to innovation and his remarkable portfolio of patents underscore his status as a pioneering figure in the realm of technology. His work not only inspires but also drives the evolution of technology, making him a true trailblazer in his field.

This text is generated by artificial intelligence and may not be accurate.